Enveric Biosciences Inc vs Rush Street Interactive Inc — how do they compare? Enveric Biosciences Inc trades at $1.39 (market cap $5.32M), while Rush Street Interactive Inc trades at $32.84 (market cap $3.39B). The key difference: Rush Street Interactive Inc is far larger — about 637.2× Enveric Biosciences Inc's market cap, and Rush Street Interactive Inc is trading nearer its 52-week high, Enveric Biosciences Inc nearer its low. Which is the better fit depends on your goals.
| ENVB | RSI | |
|---|---|---|
Market Cap | $5.32M | $3.39B |
Sector | Health | Technology |
52-Week High | $17.40 | $34.18 |
52-Week Low | $1.28 | $14.51 |
Enterprise Value | $408.82K | $3.07B |
Signals from Pluang's Aura AI — not financial advice
ENVB trades at $1.41, up 6.82% in the last session. The stock shows a bearish technical trend with moving averages signaling sell, but oscillators are neutral. Financially, the company reported a net loss of $8.77M for 2025, with negative ROE and ROA, though it consistently beat EPS expectations. Recent news highlights participation in investor conferences and progress with its neuroplastogen candidate EB-003.
Outlook is speculative with high risk due to negative profitability and cash burn, offset by strong analyst buy ratings (75%) and positive clinical updates. Key risks include funding needs and drug development hurdles, while catalysts hinge on regulatory milestones and partnership news.
Rush Street Interactive (RSI) trades at $33.57, up 0.18% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating EPS estimates with $0.14 actual versus $0.12 expected, and revenue growth to $1.13 billion in 2025. Analyst sentiment is positive with 10 buy ratings and a consensus price target of $30.44. Recent expansion into Alberta through BetRivers highlights ongoing growth initiatives.
The outlook for RSI is favorable due to robust revenue growth and strategic market expansions, though high valuation multiples like a P/E of 96.85 pose risks. Key opportunities include continued online betting demand, while risks involve competitive pressures and execution of growth strategies. The stock's momentum is supported by institutional confidence but requires monitoring of profit margin sustainability.
Trailing returns across standard periods
Latest headlines on both assets
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →Rush Street Interactive, Inc. is a digital gaming and sports betting company operating in the regulated U.S. and international markets. The company owns and operates online casino (iGaming) and sports wagering platforms, including BetRivers and PlaySugarHouse brands. RSI focuses on providing a secure and high-quality online gaming experience, leveraging its proprietary technology platform and commitment to responsible gaming.
Read more on RSI →